Corvus Pharmaceuticals

CRVS

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-27.54M

EBITDA$-62.21M

EBIT$-62.29M

Pre-tax Income$-44.17M

Net Income$-62.29M

Cash Equivalent$8.93M

Total Debt$804K

Book Value$32.39M

Book Value Per Share0.54

Return on Equity (ROE)-191.27%

Return on Assets (ROA)-90.40%

Return on Invested Capital (ROI)-191.27%

Net Profit Marginundefined

Current Ratio1.54

Quick Ratio1.49

Long-Term Debt / Equitynull